Cluster Analysis on Longitudinal Data of Patients with Adult-Onset Asthma

Journal of Allergy and Clinical Immunology: In Practice

Volumn 5, Issue 4, 2017, Pages 967-978.e3

  Ilmarinen, Pinja ^a   Tuomisto, Leena E ^a   Niemelä, Onni ^a,b   Tommola, Minna ^a   Haanpää, Jussi ^a   Kankaanranta, Hannu ^a,b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Adult onset; Asthma; Cluster analysis; Early onset; Follow up; Late onset; Longitudinal; Obesity; Phenotypes; Smoking

Indexed keywords

CORTICOSTEROID; ANTIASTHMATIC AGENT;

ADD ON THERAPY; ADOLESCENT; ADULT; ADULT ONSET ASTHMA; AGED; ARTICLE; ASTHMA; ATOPY; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMORBIDITY; DISEASE CONTROL; EOSINOPHIL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTORY; HUMAN; LUNG FUNCTION; MALE; MENTAL DISEASE; OBESITY; PHENOTYPE; RHINITIS; SMOKING; MIDDLE AGED; ONSET AGE; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CLUSTER ANALYSIS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OBESITY; PHENOTYPE; SMOKING; YOUNG ADULT;

EID: 85017353992     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2017.01.027     Document Type: Article

References (42)

1. Miranda, C., Busacker, A., Balzar, S., Trudeau, J., Wenzel, S.E., Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113 (2004), 101–108.
2. Amelink, M., de Nijs, S.B., de Groot, J.C., van Tilburg, P.M., van Spiegel, P.I., Krouwels, F.H., et al. Three phenotypes of adult-onset asthma. Allergy 68 (2013), 674–680.
3. Wenzel, S.E., Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18 (2012), 716–725.
4. Ilmarinen, P., Tuomisto, L.E., Kankaanranta, H., Phenotypes, risk factors and mechanisms of adult-onset asthma. Mediators Inflamm, 2015, 2015, 514868.
5. Moore, W.C., Meyers, D.A., Wenzel, S.E., Teague, W.G., Li, H., Li, X., et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 181 (2010), 315–323.
6. Kim, T.B., Jang, A.S., Kwon, H.S., Park, J.S., Chang, Y.S., Cho, S.H., et al. Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 41 (2013), 1308–1314.
7. Newby, C., Heaney, L.G., Menzies-Gow, A., Niven, R.M., Mansur, A., Bucknall, C., et al. Statistical cluster analysis of the British Thoracic Society Severe Refractory Asthma Registry: clinical outcomes and phenotype stability. PLoS One, 9, 2014, e102987.
8. Schatz, M., Hsu, J.W., Zeiger, R.S., Chen, W., Dorenbaum, A., Chipps, B.E., et al. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol 133 (2014), 1549–1556.
9. Bourdin, A., Molinari, N., Vachier, I., Varrin, M., Marin, G., Gamez, A.S., et al. Prognostic value of cluster analysis of severe asthma phenotypes. J Allergy Clin Immunol 134 (2014), 1043–1050.
10. Haldar, P., Pavord, I.D., Shaw, D.E., Berry, M.A., Thomas, M., Brightling, C.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178 (2008), 218–224.
11. Kankaanranta, H., Ilmarinen, P., Kankaanranta, T., Tuomisto, L.E., Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care. NPJ Prim Care Respir Med, 25, 2015, 15042.
12. Tuomisto, L.E., Ilmarinen, P., Niemelä, O., Haanpää, J., Kankaanranta, T., Kankaanranta, H., A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. Respir Med 117 (2016), 223–229.
13. Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
14. Tommola, M., Ilmarinen, P., Tuomisto, L.E., Haanpää, J., Kankaanranta, T., Niemelä, O., et al. The effect of smoking on lung function: a clinical study on adult-onset asthma. Eur Respir J 48 (2016), 1298–1306.
15. Global Initiative for Asthma. From the global strategy for asthma management and prevention. Available from: www.ginasthma.org/. Accessed October 27, 2014.
16. Barley, E.A., Quirk, F.H., Jones, P.W., Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 92 (1998), 1207–1214.
17. Nathan, R.A., Sorkness, C.A., Kosinski, M., Schatz, M., Li, J.T., Marcus, P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004), 59–65.
18. Global Initiative for Asthma; Global Initiative for Chronic Obstructive Lung Disease. Asthma, COPD and asthma-COPD overlap syndrome (ACOS). Available from: www.goldcopd.org/. Accessed April 2, 2015.
19. Kaneko, Y., Masuko, H., Sakamoto, T., Iijima, H., Naito, T., Yatagai, Y., et al. Asthma phenotypes in Japanese adults—their associations with the CCL5 and ADRB2 genotypes. Allergol Int 62 (2013), 113–121.
20. Eisner, M.D., Iribarren, C., The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 9 (2007), 53–56.
21. Thomson, N.C., Chaudhuri, R., Heaney, L.G., Bucknall, C., Niven, R.M., Brightling, C.E., et al. Clinical outcomes and inflammatory biomarkers in current smokers and ex-smokers with severe asthma. J Allergy Clin Immunol 131 (2013), 1008–1016.
22. Kauppi, P., Kupiainen, H., Lindqvist, A., Haahtela, T., Laitinen, T., Long-term smoking increases the need for acute care among asthma patients: a case control study. BMC Pulm Med, 14, 2014, 119.
23. Kankaanranta, H., Kauppi, P., Tuomisto, L.E., Ilmarinen, P., Emerging co-morbidities in adult asthma: risks, clinical associations and mechanisms. Mediators Inflamm, 2016, 2016, 3690628.
24. Boudreau, M., Bacon, S.L., Ouellet, K., Jacob, A., Lavoie, K.L., Mediator effect of depressive symptoms on the association between BMI and asthma control in adults. Chest 146 (2014), 348–354.
25. Ilmarinen, P., Tuomisto, L.E., Niemelä, O., Danielsson, J., Haanpää, J., Kankaanranta, T., et al. Co-morbidities and elevated IL-6 associate with negative outcome in adult-onset asthma. Eur Respir J 48 (2016), 1052–1062.
26. Zein, J.G., Erzurum, S.C., Asthma is different in women. Curr Allergy Asthma Rep, 15, 2015, 28.
27. Tan, K.S., McFarlane, L.C., Lipworth, B.J., Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients. Thorax 52 (1997), 608–611.
28. Triebner, K., Johannessen, A., Puggini, L., Benediktsdottir, B., Bertelsen, R.J., Bifulco, E., et al. Menopause as a predictor of new-onset asthma: a longitudinal Northern European population study. J Allergy Clin Immunol 137 (2016), 50–57.e6.
29. Troisi, R.J., Speizer, F.E., Willett, W.C., Trichopoulos, D., Rosner, B., Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma: a prospective cohort study. Am J Respir Crit Care Med 152 (1995), 1183–1188.
30. Romieu, I., Fabre, A., Fournier, A., Kauffmann, F., Varraso, R., Mesrine, S., et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax 65 (2010), 292–297.
31. Gomez Real, F., Svanes, C., Bjornsson, E.H., Franklin, K.A., Gislason, D., Gislason, T., et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax 61 (2006), 34–40.
32. Bousquet, J., Schunemann, H.J., Samolinski, B., Demoly, P., Baena-Cagnani, C.E., Bachert, C., et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 130 (2012), 1049–1062.
33. Ciprandi, G., Caimmi, D., Miraglia Del Giudice, M., La Rosa, M., Salpietro, C., Marseglia, G.L., Recent developments in united airways disease. Allergy Asthma Immunol Res 4 (2012), 171–177.
34. Ballantyne, D., Scott, H., MacDonald-Wicks, L., Gibson, P.G., Wood, L., Resistin is a predictor of asthma risk and resistin: adiponectin ratio is a negative predictor of lung function in asthma. Clin Exp Allergy 46 (2016), 1056–1065.
35. Scott, H.A., Gibson, P.G., Garg, M.L., Upham, J.W., Wood, L.G., Sex hormones and systemic inflammation are modulators of the obese-asthma phenotype. Allergy 71 (2016), 1037–1047.
36. Tuomisto, L.E., Ilmarinen, P., Kankaanranta, H., Prognosis of new-onset asthma diagnosed at adult age. Respir Med 109 (2015), 944–954.
37. Zein, J.G., Dweik, R.A., Comhair, S.A., Bleecker, E.R., Moore, W.C., Peters, S.P., et al. Asthma is more severe in older adults. PLoS One, 10, 2015, e0133490.
38. Westerhof, G.A., Korevaar, D.A., Amelink, M., de Nijs, S.B., de Groot, J.C., Wang, J., et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J 46 (2015), 688–696.
39. Viljanen, A.A., Halttunen, P.K., Kreus, K.E., Viljanen, B.C., Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 159 (1982), 5–20.
40. American Thoracic Society; European Respiratory Society, ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005), 912–930.
41. Barnett, K., Mercer, S.W., Norbury, M., Watt, G., Wyke, S., Guthrie, B., Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380 (2012), 37–43.
42. Ilmarinen, P., Tuomisto, L.E., Niemelä, O., Danielsson, J., Haanpää, J., Kankaanranta, T., et al. Co-morbidities and elevated IL-6 associate with negative outcome in adult-onset asthma. Eur Respir J 48 (2016), 1052–1062.